PL378586A1 - Calciferol analogue application in cancer treatment - Google Patents

Calciferol analogue application in cancer treatment

Info

Publication number
PL378586A1
PL378586A1 PL378586A PL37858605A PL378586A1 PL 378586 A1 PL378586 A1 PL 378586A1 PL 378586 A PL378586 A PL 378586A PL 37858605 A PL37858605 A PL 37858605A PL 378586 A1 PL378586 A1 PL 378586A1
Authority
PL
Poland
Prior art keywords
calciferol
cancer treatment
analogue application
analogue
application
Prior art date
Application number
PL378586A
Other languages
Polish (pl)
Inventor
Andrzej Kutner
Michał Chodyński
Hanna Fitak
Małgorzata Krupa
Joanna Wietrzyk
Wiesław Szelejewski
Original Assignee
Instytut Farmaceutyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Farmaceutyczny filed Critical Instytut Farmaceutyczny
Priority to PL378586A priority Critical patent/PL378586A1/en
Publication of PL378586A1 publication Critical patent/PL378586A1/en

Links

PL378586A 2005-12-29 2005-12-29 Calciferol analogue application in cancer treatment PL378586A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL378586A PL378586A1 (en) 2005-12-29 2005-12-29 Calciferol analogue application in cancer treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL378586A PL378586A1 (en) 2005-12-29 2005-12-29 Calciferol analogue application in cancer treatment

Publications (1)

Publication Number Publication Date
PL378586A1 true PL378586A1 (en) 2007-07-09

Family

ID=43015134

Family Applications (1)

Application Number Title Priority Date Filing Date
PL378586A PL378586A1 (en) 2005-12-29 2005-12-29 Calciferol analogue application in cancer treatment

Country Status (1)

Country Link
PL (1) PL378586A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010143986A1 (en) 2009-06-10 2010-12-16 Instytut Farmaceutyczny Combined therapy of colorectal carcinoma
WO2012128653A1 (en) 2011-03-18 2012-09-27 Instytut Farmaceutyczny Use of anastrozole and vitamin d analogue in the combined therapy of breast cancer

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010143986A1 (en) 2009-06-10 2010-12-16 Instytut Farmaceutyczny Combined therapy of colorectal carcinoma
WO2012128653A1 (en) 2011-03-18 2012-09-27 Instytut Farmaceutyczny Use of anastrozole and vitamin d analogue in the combined therapy of breast cancer

Similar Documents

Publication Publication Date Title
HK1201182A1 (en) Pegylated il-10 for use in treating cancer or tumor il-10
HK1123509A1 (en) Hair treatment compositions
EP1863899A4 (en) Skin treatment compositions
IL186408A0 (en) Combination treatment methods
SI2450041T1 (en) Improved testosterone gel for use in the treatment of hypogonadism
IL194202A0 (en) Treatment using citrulline
EP1858587A4 (en) Aesthetic treatment device
PT2101731T (en) Endoxifen for use in the treatment of cancer
PT1830847E (en) Treatment for cancer
EP1855662A4 (en) Methods and compositions for treating cancer
AU2006251169A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
AU2006251167A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
GB0516068D0 (en) Well treatment
GB0515138D0 (en) Acne treatment
GB0525540D0 (en) New treatment
ZA200709542B (en) Combination therapy in the treatment of cancer
GB0428187D0 (en) Cancer treatment
GB0511769D0 (en) Treatment
GB0413346D0 (en) Treating cancer
GB0502171D0 (en) Well treatment
PL378586A1 (en) Calciferol analogue application in cancer treatment
GB0525535D0 (en) Tumour treatment
GB0507685D0 (en) Cancer treatment
GB0505203D0 (en) Skin composition treatment
GB0523291D0 (en) Treatment table

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)